StockData
Vogenx, Inc. logo

Vogenx, Inc. (VOGX) stock

VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)

Close on Nov 17, 2026Market cap $200.25MP/E –Yield –

Vogenx total assets

Total assets on the balance sheet at the end of each period.

Vogenx's total assets was $1.41M at Jun 30, 2026. For fiscal 2025 it was $681.17K.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$681.17K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.41M–
Q4 FY2025Dec 31, 2025$681.17K–

More Vogenx figures

See a number that looks wrong?